Abstract
High dose of cytosine arabinoside is usually used in treatment of acute myelogenous leukemia. Here we report 1 case of a child who developed neurologic toxicity and rapidly improved after flushing out of cerebral spinal fluid, suggesting it could be treatment in the acute phase of toxicity. Efficacy of this treatment could be explained by reducing cytosine arabinoside metabolites in central nervous system.
MeSH terms
-
Adolescent
-
Antimetabolites, Antineoplastic / administration & dosage
-
Antimetabolites, Antineoplastic / adverse effects*
-
Cerebellar Diseases / chemically induced*
-
Cerebellar Diseases / therapy*
-
Cerebrospinal Fluid*
-
Cytarabine / administration & dosage
-
Cytarabine / adverse effects*
-
Humans
-
Leukemia, Myeloid, Acute / complications
-
Leukemia, Myeloid, Acute / drug therapy*
-
Male
Substances
-
Antimetabolites, Antineoplastic
-
Cytarabine